Torsten Haferlach

58PUBLICATIONS
342CO-AUTHORS
Microbiology not elsewhere classifiedMedical mycologyGene and molecular therapyHaematological tumoursMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (58)

|Aug 10, 2026
MDS without clonal marker: when depth outperforms breadth.

|Jul 13, 2026
Subclonal MECOM rearrangements in myeloid neoplasms: enriched for TP53 mutations and adverse outcome.

|Jul 13, 2026
The novel hypomethylating agent NTX-301 reprograms epigenetic and Hippo signaling pathways and exhibits pre-clinical activity in venetoclax-resistant and TP53-mutant AML.

|Jun 08, 2026
Comprehensive landscape of secondary cytogenetic and molecular genetic events in multiple myeloma patients at diagnosis.

|May 09, 2026
The clinical relevance of sole loss of chromosome Y in myeloid neoplasms.

|Mar 25, 2026
Flare of clonal hematopoiesis, TP53 expansion and prior melphalan drive post-CAR-T myeloid disorders in multiple myeloma.

Johannes Waldschmidt, David Fandrei, Judith S Hecker

Pageof 10

Frequent Collaborators

24 joint publications

Claudia Haferlach

20 joint publications

Manja Meggendorfer

19 joint publications

Wolfgang Kern

16 joint publications

Stephan Hutter